Benjamin Bert, MD , a board-certified ophthalmologist at MemorialCare Orange Coast Medical Center in Fountain Valley, California, added that as GLP-1s help with controlling blood sugar, their use may also lead to changes in vision prescription
In the 2023 New England Journal of Medicine Phase 2 obesity trial, participants receiving the highest doses (12 mg weekly) achieved an average body weight reduction of approximately 24% over 48 weeks , alongside structured lifestyle support
But as research continues to reveal their benefitsespecially for patients at high risk of recurrenceinsurers should weigh long-term health outcomes over short-term costs
The interesting part: BPC-157 appears to work on the gut-brain axis, which might explain the mental clarity improvements I wasnt expecting
GLP-1 agonists including semaglutide slow gastric emptying, which can intensify alcohol effects and increase nausea risk